CG FV (Femara 2.5 mg)

Generic Name: letrozole

Pill imprint CG FV has been identified as Femara 2.5 mg.

Femara is used in the treatment of female infertility; breast cancer, metastatic; breast cancer, adjuvant; breast cancer and belongs to the drug classes aromatase inhibitors, hormones/antineoplastics. There is positive evidence of human fetal risk during pregnancy. Femara 2.5 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for CG FV

Femara 2.5 mg CG FV
Femara 2.5 mg CG FV Front
Femara 2.5 mg CG FV Back
Femara 2.5 mg CG FV
Femara
Generic Name:
letrozole
Imprint:
CG
FV
Strength:
2.5 mg
Color:
Yellow
Size:
7.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Aromatase inhibitors
Hormones/antineoplastics
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Novartis Pharmaceuticals
National Drug Code (NDC):
00078-0249
Inactive Ingredients:
silicon dioxide
ferric oxide red
hypromelloses
lactose monohydrate
magnesium stearate
corn starch
microcrystalline cellulose
polyethylene glycol
sodium starch glycolate type A potato
magnesium silicate
titanium dioxide
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
54868-4151 Physicians Total Care Inc (repackager)
54569-5714 A S Medication Solutions LLC (repackager)
35356-0409 Lake Erie Medical and Surgical Supply (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web2)